Source: Annual Congress 2006 - Epidemiology of susceptible, resistant and multidrug-resistant tuberculosis (MDR-TB)
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. Danusantoso, Yulismar, G. T. The (Jakarta, Indonesia; Almere, Netherlands). A joint TB re-treatment project for the poor. Eur Respir J 2006; 28: Suppl. 50, 2245

Member's Comments

No comment yet.

Related content which might interest you: Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 MDR-TB treatment outcomes in HIV positive patients Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia Source: ERJ Open Res, 6 (1) 00030-2019; 10.1183/23120541.00030-2019 Year: 2020 Problems with poor study adherence in a tuberculosis research project in children in Tanzania Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 Follow-up of TB cases failing or defaulting the first TB treatment, in Romania Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Predictors of defaulting from treatment among patients with tuberculosis Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 MDR-TB guidelines: what is new on clinical management Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management Year: 2020 Treatment effectiveness and predictors of poor outcome in MDR-TB and XDR-TB Source: Breathe 2008; 6: 161 Year: 2009 Outcomes of DOTS and DOTS Plus regimens implementing among patients with pulmonary tuberculosis relapses Source: Eur Respir J 2002; 20: Suppl. 38, 369s Year: 2002 Could side effects of MDR-TB treatment change the outcome of the disease? Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Which is the level of education among TB and MDR TB patients about their disease? A patient‘s questionnaire Source: Eur Respir J 2006; 28: Suppl. 50, 588s Year: 2006 Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses Source: Eur Respir J 2001; 18: Suppl. 33, 473s Year: 2001 Factors responsible for relapse under revised national tuberculosis control programme (RNTCP) Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 Significance of low cost pulmonary rehabilitation programme in post-pulmonary tubercular sequelae in patients of low socio-economic marginalized communities in India:Microbiological cure is the beginning and not the end of their illness. Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Treatment outcomes of new cases of polyresistant pulmonary TB with second line anti-TB drugs in DOTS-Plus regimen Source: Eur Respir J 2002; 20: Suppl. 38, 359s Year: 2002 HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015